{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T23:19:51Z","timestamp":1777763991786,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ygyno.2026.02.015","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:54:27Z","timestamp":1776387267000},"page":"53-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"S","title":["Impact of a community-centered intervention on knowledge, confidence, and attitudes toward clinical trials: A pilot survey study"],"prefix":"10.1016","volume":"207","author":[{"given":"Oriana","family":"Krivenko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Antonio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dario","family":"Roque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ygyno.2026.02.015_bb0005","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.46494","article-title":"Racial and ethnic disparities in clinical trial enrollment among women with gynecologic cancer","volume":"6","author":"Khadraoui","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.ygyno.2026.02.015_bb0010","series-title":"U.S. Cancer Statistics Data Visualizations Tool","author":"Department of Health and Human Services CfDCaPaNCI. U.S. Cancer Statistics Working Group","year":"2025"},{"issue":"2","key":"10.1016\/j.ygyno.2026.02.015_bb0015","first-page":"111","article-title":"Cancer statistics for African American and black people, 2025","volume":"75","author":"Saka","year":"2025","journal-title":"CA Cancer J. Clin."},{"issue":"6","key":"10.1016\/j.ygyno.2026.02.015_bb0020","first-page":"466","article-title":"Cancer statistics for the US Hispanic\/Latino population, 2021","volume":"71","author":"Miller","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"4","key":"10.1016\/j.ygyno.2026.02.015_bb0025","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1177\/107327481602300404","article-title":"Barriers to clinical trial enrollment in racial and ethnic minority patients with cancer","volume":"23","author":"Hamel","year":"2016","journal-title":"Cancer Control"},{"key":"10.1016\/j.ygyno.2026.02.015_bb0030","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ygyno.2023.05.006","article-title":"Inclusion, diversity, equity, and access (IDEA) in gynecologic cancer clinical trials: a joint statement from GOG foundation and Society of Gynecologic Oncology (SGO)","volume":"174","author":"Pothuri","year":"2023","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2026.02.015_bb0035","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/GRF.0000000000000765","article-title":"Enrollment of racial and ethnic minoritized groups in gynecologic oncology clinical trials: a review of the scope of the problem, contributing factors, and strategies to improve inclusion","volume":"66","author":"Barry","year":"2023","journal-title":"Clin. Obstet. Gynecol."},{"issue":"10434","key":"10.1016\/j.ygyno.2026.02.015_bb0040","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0140-6736(24)00317-9","article-title":"Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11\/GOG-3047\/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial","volume":"403","author":"Lorusso","year":"2024","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ygyno.2026.02.015_bb0045","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1056\/NEJMoa2108330","article-title":"Lenvatinib plus pembrolizumab for advanced endometrial cancer","volume":"386","author":"Makker","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.ygyno.2026.02.015_bb0050","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1080\/10410236.2021.1943978","article-title":"Community-based participatory research (CBPR) to enhance participation of racial\/ethnic minorities in clinical trials: a 10-year systematic review","volume":"37","author":"Julian McFarlane","year":"2022","journal-title":"Health Commun."},{"issue":"13","key":"10.1016\/j.ygyno.2026.02.015_bb0055","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1200\/JCO.23.01290","article-title":"Systematic review of interventions addressing racial and ethnic disparities in cancer care and health outcomes","volume":"42","author":"Grant","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2026.02.015_bb0060","series-title":"Psychometric Theory","author":"Nunnally JC BI","year":"1994"},{"issue":"9295","key":"10.1016\/j.ygyno.2026.02.015_bb0065","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1016\/S0140-6736(01)06805-2","article-title":"Quality of informed consent in cancer clinical trials: a cross-sectional survey","volume":"358","author":"Joffe","year":"2001","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ygyno.2026.02.015_bb0070","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.57020","article-title":"Understanding of clinical trials among patients with cancer and their relatives","volume":"8","author":"Kubilay Tolunay","year":"2025","journal-title":"JAMA Netw. Open"},{"issue":"7","key":"10.1016\/j.ygyno.2026.02.015_bb0075","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/j.1532-5415.1998.tb02725.x","article-title":"Perceived efficacy in patient-physician interactions (PEPPI): validation of an instrument in older persons","volume":"46","author":"Maly","year":"1998","journal-title":"J. Am. Geriatr. Soc."},{"issue":"1","key":"10.1016\/j.ygyno.2026.02.015_bb0080","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/0272989X9501500105","article-title":"Validation of a decisional conflict scale","volume":"15","author":"O\u2019Connor","year":"1995","journal-title":"Med. Decis. Mak."},{"issue":"2","key":"10.1016\/j.ygyno.2026.02.015_bb0085","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1037\/a0022598","article-title":"Moral anger, but not moral disgust, responds to intentionality","volume":"11","author":"Russell","year":"2011","journal-title":"Emotion"},{"key":"10.1016\/j.ygyno.2026.02.015_bb0090","series-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen","year":"1988"},{"issue":"1","key":"10.1016\/j.ygyno.2026.02.015_bb0095","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-020-08939-4","article-title":"Formative research to design a culturally-appropriate cancer clinical trial education program to increase participation of African American and Latino communities","volume":"20","author":"Cunningham-Erves","year":"2020","journal-title":"BMC Public Health"},{"issue":"22","key":"10.1016\/j.ygyno.2026.02.015_bb0100","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1001\/jama.291.22.2720","article-title":"Participation in cancer clinical trials: race-, sex-, and age-based disparities","volume":"291","author":"Murthy","year":"2004","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ygyno.2026.02.015_bb0105","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1200\/JOP.2017.025288","article-title":"Representation of minorities and women in oncology clinical trials: review of the past 14 years","volume":"14","author":"Duma","year":"2018","journal-title":"J. Oncol. Pract."},{"issue":"7","key":"10.1016\/j.ygyno.2026.02.015_bb0110","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1001\/jamadermatol.2023.1285","article-title":"The skin of color society\u2019s meeting the challenge summit, 2022: diversity in dermatology clinical trials proceedings","volume":"159","author":"Cobb","year":"2023","journal-title":"JAMA Dermatol."},{"issue":"3","key":"10.1016\/j.ygyno.2026.02.015_bb0115","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/cpt.2819","article-title":"Enhancing diversity and inclusion in clinical trials","volume":"113","author":"Corneli","year":"2023","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ygyno.2026.02.015_bb0120","series-title":"NIH Policy and Guidelines on the Inclusion of Women and Minorities as Subjects in Clinical Research","year":"2017"},{"key":"10.1016\/j.ygyno.2026.02.015_bb0125","article-title":"Race\/ethnicity reporting and representation in US clinical trials: a cohort study","volume":"11","author":"Turner","year":"2022","journal-title":"Lancet Reg. Health Am."},{"issue":"2","key":"10.1016\/j.ygyno.2026.02.015_bb0130","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.2105\/AJPH.2013.301706","article-title":"A systematic review of barriers and facilitators to minority research participation among African Americans, Latinos, Asian Americans, and Pacific islanders","volume":"104","author":"George","year":"2014","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.ygyno.2026.02.015_bb0135","doi-asserted-by":"crossref","DOI":"10.1200\/OP-25-00422","article-title":"\u201cWhy I said no\u201d: trial-eligible patient perspectives on declining breast cancer clinical trial participation","author":"Reh","year":"2025","journal-title":"JCO Oncol. Pract."},{"issue":"4","key":"10.1016\/j.ygyno.2026.02.015_bb0140","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.amjms.2023.07.011","article-title":"Clinical trial participation among underserved communities: insights from the Louisiana community engagement alliance","volume":"366","author":"Craig","year":"2023","journal-title":"Am J Med Sci"},{"issue":"2","key":"10.1016\/j.ygyno.2026.02.015_bb0145","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ygyno.2020.01.040","article-title":"Are ethnic and racial minority women less likely to participate in clinical trials?","volume":"157","author":"Patel","year":"2020","journal-title":"Gynecol. Oncol."},{"issue":"7","key":"10.1016\/j.ygyno.2026.02.015_bb0150","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1377\/hlthaff.2020.02356","article-title":"Chilling effects: US immigration enforcement and health care seeking among Hispanic adults","volume":"40","author":"Friedman","year":"2021","journal-title":"Health Aff. (Millwood)."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825826008097?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825826008097?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T14:58:28Z","timestamp":1777474708000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825826008097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":30,"alternative-id":["S0090825826008097"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2026.02.015","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of a community-centered intervention on knowledge, confidence, and attitudes toward clinical trials: A pilot survey study","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2026.02.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}